By Turna Ray
Almac Diagnostics announced this week that it will serve as the reference lab for Exonhit's AclarusDx test for Alzheimer's diagnosis.
Under the terms of the agreement, Paris-based Exonhit will focus on marketing AclarusDx while Almac will run the test in its accredited laboratory in Craigavon, UK, and deliver the results to clinicians.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
